St. Louis biotech startup Arch Oncology raises $105M in Series C funding

St. Louis Business Journal

Apr 27, 2021

The startup, which has operations in St. Louis and Brisbane, California, said its $105 million financing will accelerate clinical efforts to advance its lead cancer fighting drug.